Smithfield Foods reported third quarter 2026 sales of $3.4 billion, an 8.3% decrease year-over-year, driven by pressure in upstream pork commodity markets. Despite the decline, the Packaged Meats segment delivered higher operating profit and the company completed its acquisition of Nathan’s Famous to bolster its brand portfolio.
Term
Q3 2026
“We reported third quarter adjusted operating profit within the range we provided in September, led by strong results in our cornerstone Packaged Meats segment, with our upstream segments challenged by lower pork commodity markets.”
Shane Smith, President and CEO
“Packaged Meats remains on track to deliver its fifth consecutive year above $1 billion in operating profit in fiscal 2026. The completion of the Nathan’s Famous acquisition further strengthens our brand portfolio and expands our opportunities for profitable growth.”
Central Bancompany reported Q3 2026 net income of $116.2 million, or $0.48 per diluted share, driven by net interest margin expansion to 4.48%. The company saw average total deposits grow 4.4% year-over-year to $15.4 billion, while maintaining strong asset quality with nonperforming assets at just 33 basis points of total assets.
Term
3 years
“We delivered another strong quarter, supported by continued balance sheet growth, disciplined expense management, and solid credit quality. Adjusted net income increased $13.7 million from a year ago and $2.8 million from the prior quarter.”
John “JR” Ross, President and Chief Executive Officer
“Underlying business fundamentals remained healthy across our franchise. Average total deposits increased more than 4% from the prior-year quarter, including 6% growth in noninterest-bearing deposits, while average loans grew at an annualized rate of more than 3% from the prior quarter despite our continued focus on reducing certain consumer loan balances.”
John “JR” Ross, President and Chief Executive Officer
Skyline Bankshares reported record third-quarter net income of $5.1 million, or $0.90 per share, driven by organic loan growth and an expanded net interest margin of 4.61%. Total assets grew to $1.35 billion, supported by a 6.92% increase in net loans since the end of 2025. The company also expanded its footprint with the opening of a new branch in Dobson, North Carolina.
Term
Q3 2026
“We are pleased to report another quarter of record earnings for Skyline while continuing to invest in future growth, including the September opening of our newest branch in Dobson, North Carolina.”
Blake Edwards, President and CEO
“We believe we remain well positioned for continued growth and success in the future and look forward to the opportunities ahead for the Skyline family.”
Wave Life Sciences reported total assets of $507.9 million as of September 30, 2026, a decrease from $638.5 million at year-end 2025, primarily driven by a reduction in cash and cash equivalents. The company transitioned a significant portion of its liquidity into marketable securities and reported 197,228,968 shares of common stock outstanding as of October 21, 2026.
Commvault Systems reported Q2 fiscal 2027 results with subscription revenue growing 21% year-over-year to $269 million and subscription ARR reaching $1.1 billion. The company raised its full-year fiscal 2027 guidance for subscription revenue and ARR, citing strong momentum in enterprise cyber resilience and AI-driven demand.
Term
Q2 2027
“With AI accelerating both innovation and risk in the enterprise, resilience continues to be a business imperative. Enterprises globally are increasingly turning to Commvault to stay resilient as they navigate more data, more identities, and greater complexity. We believe our strong Q2 results reflect that momentum, driving durable growth and shareholder value.”
Norwood Financial Corp reported record Q3 2026 net income of $11.8 million and record net interest income of $28.0 million. Results were driven by disciplined execution and contributions from the Presence Bank acquisition, alongside a net interest margin expansion to 4.01%.
Term
Q3 2026
“The entire Wayne Bank team continued to perform well in the third quarter, delivering record net income and net interest income for the second consecutive quarter. In addition to strong income growth, we navigated the bankruptcy related to a borrower relationship, resolving the issue with favorable outcome.”
Jim Donnelly, President and Chief Executive Officer
Zura Bio reported third quarter 2026 financial results, highlighting a cash position of $187.7 million which is expected to fund operations through 2028. The company remains on track for topline Phase 2 data readouts for tibulizumab in hidradenitis suppurativa (Q4 2026) and systemic sclerosis (H1 2027).
“Our team continues to execute efficiently on our development plan for tibulizumab, and we are excited as we enter this data-rich period for the company. We are on track to report topline results from our TibuSHIELD study in HS later this quarter, followed by topline results from our TibuSURE study in SSc in the first half of 2027.”
Sandeep Kulkarni, M.D., co-founder and Chief Executive Officer
“We continue to believe deeply in tibulizumab’s potential to address complex immune biology and unmet needs across indications, including in PMR, where we will be starting the NEXUS-PMR study by end of year. With cash runway sufficient to deliver results from all three studies, Zura is in a great position to deliver on tibulizumab’s unique potential.”
Sandeep Kulkarni, M.D., co-founder and Chief Executive Officer
Zura Bio Limited reported a net loss of $76.4 million for the nine months ended September 30, 2026, driven by increased research and development expenses. The company strengthened its balance sheet during the period, ending with $187.7 million in cash and cash equivalents compared to $109.4 million at the end of 2025.
Nautilus Biotechnology reported total revenue of $424,000 for the nine months ended September 30, 2026, primarily from grant and service revenue, compared to zero revenue in the prior year. The company's total assets decreased from $191.1 million at the end of 2025 to $148.9 million as of September 30, 2026, driven by an accumulated deficit of $376.8 million.
Wave Life Sciences reported Q3 2026 financial results, highlighting a cash position of $431 million and an expected runway into Q3 2028. The company is advancing its RNA editing and siRNA clinical programs, including planning for a registrational trial of WVE-006 in AATD and ongoing Phase 2a dosing for WVE-007 in obesity.
Term
Q3 2026
“Following positive FDA feedback, planning is underway for our potentially registrational trial of WVE-006 for AATD, which we believe offers an efficient path to potential full and accelerated approval, without the need for a separate confirmatory trial.”
Paul Bolno, MD, MBA, President and Chief Executive Officer
“Importantly, our PRISM platform and chemistry continue to demonstrate unique value both within our own pipeline and beyond. The advancement of a development candidate by GSK reflects the recognition of Wave’s differentiated technology, including our best-in-class siRNA with SpiNA design, with three additional collaboration programs still advancing.”
Paul Bolno, MD, MBA, President and Chief Executive Officer
Kiniksa Pharmaceuticals International Financial Results
Kiniksa Pharmaceuticals reported Q3 2026 financial results, highlighted by ARCALYST net product revenue of $286.0 million, a 58% year-over-year increase. The company raised its full-year 2026 ARCALYST net product revenue guidance to a range of $1.045 billion to $1.050 billion.
“Kiniksa continues to build a leading IL-1α and IL-1β inhibition franchise, driven by the commercialization of ARCALYST in recurrent pericarditis. In the third quarter, strong commercial execution led to gains in patient and physician adoption, resulting in revenue of $286.0 million and positioning ARCALYST to achieve blockbuster status this year”
Sanj K. Patel, Chairman & Chief Executive Officer of Kiniksa
Boeing reported third quarter 2026 revenue of $24.2 billion and a net loss of $116 million, reflecting higher defense and services volume. The company achieved a record backlog of $745 billion and noted key milestones including FAA certification for the 737-7 and 737-10 aircraft.
Term
Q3 2026
“Recent milestones, including certification of the 737-7 and 737-10 and selection to design and build the Navy’s sixth-generation fighter aircraft, are important steps as we continue building on our progress. But we are not done. We remain focused on safety and quality as we redouble our efforts on Lean and disciplined execution to deliver on our commitments and build the durable performance our stakeholders expect.”
Kelly Ortberg, Boeing president and chief executive officer
Watsco reported record third quarter sales of $2.22 billion, a 7% increase year-over-year, driven by stabilization in residential demand and recent acquisitions. The company recently completed the acquisitions of Jackson Supply Company and The Granite Group, which are expected to increase annual revenue by approximately 10%.
Celestica Inc. reported its financial results for the third quarter ended September 30, 2026, alongside an Investor and Analyst Day presentation. The company disclosed GAAP earnings from operations of $460.0 million for Q3 2026 and a year-to-date GAAP ROIC of 55.9%.
HCA Healthcare reported third quarter 2026 revenues of $19.85 billion, a 3.6% increase year-over-year, despite an estimated $400 million headwind from an unfavorable payer mix shift. The company also declared a quarterly cash dividend of $0.78 per share and indicated that full-year results are expected to be in the upper half of its previously issued guidance range.
Term
Q3 2026
“I have often mentioned that HCA has strong staying power because of our scale, the important role we play in providing critical services to communities, and our disciplined culture. Despite the challenges brought about by federal policy changes this year, our colleagues have continued to provide high-quality care to patients, and we believe HCA Healthcare is positioned to end the year positively.”
Sam Hazen, Chief Executive Officer of HCA Healthcare
S&P Global reported Q3 2026 revenue of $3.68 billion, a 7% year-over-year increase, and initiated a strategic review for its Capital IQ and associated data businesses. The company also completed the spin-off of its Mobility division into an independent public company, Mobility Global, on July 1, 2026.
“S&P Global delivered a very strong quarter. Increasing demand for our benchmarks and unique intellectual property demonstrates our leadership in credit, equity, and commodities markets. Our focus on new high-growth adjacencies and our innovation are resonating deeply with customers around the world. The businesses that are part of the strategic review are strong and have significant opportunities ahead of them as technology changes how customers access, analyze, and use information. This reflects our long-standing commitment to be good stewards of our portfolio, while prioritizing our investments where we’re strongest.”
IQVIA reported third-quarter 2026 revenue of $4.43 billion, up 8.0% year-over-year, driven by strong growth in R&D Solutions and Commercial Solutions. The company achieved record clinical bookings of $3.2 billion and raised its full-year 2026 guidance for revenue, Adjusted EBITDA, and Adjusted Diluted EPS.
“IQVIA delivered another record quarter, with revenue, Adjusted EBITDA and Adjusted Diluted EPS all exceeding the high end of our expectations. Multiple demand indicators continue to validate the strengthening market environment. EBP funding, RFP flow, clinical trial starts, FDA approvals, outsourcing trends, and pipeline growth across clinical and commercial are all favorable.”
Sherwin-Williams reported third quarter 2026 consolidated net sales growth of 7.9% to $6.86 billion, driven by gains across all reportable segments and selling price increases. While net income decreased slightly to $821 million, adjusted diluted EPS rose to $3.63, and the company narrowed its full-year adjusted earnings guidance.
Term
3 months
“Sherwin-Williams third quarter performance demonstrated the resilience of our Company and the strength of our strategy in a challenging demand environment. Despite muted underlying market volumes, we continued to win new customers, increase share-of-wallet and deliver sales growth across all three reportable segments, at or above our guidance, supported by the differentiated value and productivity our solutions deliver to customers.”
Heidi G. Petz, Chair, President and Chief Executive Officer
“We returned $749.0 million to shareholders in the quarter through dividends and share repurchases. Our team remains focused on serving our customers and controlling what we can control to continue top and bottom-line growth.”
Heidi G. Petz, Chair, President and Chief Executive Officer
Galaxy Digital reported Q3 2026 net income of $323 million, a significant recovery from a net loss in the prior quarter, driven by digital asset franchise strength and investment portfolio appreciation. The company also announced a $200 million increase to its share repurchase authorization and highlighted a $3.5 billion senior secured notes offering to fund its Helios data center expansion.
Term
Q3 2026
“Galaxy delivered a strong third quarter, reflecting the strength of our established Digital Assets franchise, significant appreciation across our investments portfolio, and the growing contribution from our Data Centers business. Our strategy is centered on two significant opportunities in the global economy: the modernization of financial markets through digital assets and the expansion of AI infrastructure. The progress we're making across both businesses is strengthening and diversifying our earnings profile, while positioning Galaxy to capitalize on substantial growth opportunities. We remain focused on disciplined execution and creating long-term value for our shareholders.”
Mike Novogratz, Founder and Chief Executive Officer
Repligen Corporation reported record third-quarter 2026 revenue of $209.3 million, representing 11% reported and 12.5% organic growth. The company also announced the completion of its BioLife Solutions acquisition in October and raised its full-year 2026 revenue guidance to a range of $844-$852 million.
“We delivered a record third quarter, with $209 million in revenue and 12.5% organic growth, driven by continued strength across our diversified portfolio. End-market demand continues to improve, with healthy trends in consumables and services complemented by a growing capital equipment order book.”
Olivier Loeillot, President and Chief Executive Officer
“The completion of the BioLife acquisition in October marks a significant milestone for Repligen, and integration is progressing well. Early customer feedback has been very encouraging, and we have already taken actions to realize a sizable portion of our expected operating expense synergies. Our strong year-to-date performance, continued order momentum and the addition of BioLife give us confidence to raise our full-year guidance again.”
Olivier Loeillot, President and Chief Executive Officer
American Tower reported third-quarter 2026 financial results with total revenue increasing 2.5% to $2.79 billion, driven by leasing demand and data center outperformance. The company raised its full-year 2026 outlook and authorized an additional $2.0 billion for future share repurchases.
“We delivered another solid quarter, supported by consistent leasing demand across our global tower portfolio and continued outperformance from CoreSite. This momentum, combined with disciplined capital allocation, enabled us to raise our full-year outlook for the third time this year.”
Steve Vondran, American Tower’s Chief Executive Officer
“Our results reflect the strength of our business and a portfolio that has become increasingly focused on high-quality assets and attractive growth opportunities. The actions we have taken to simplify the portfolio and enhance financial flexibility are creating a stronger foundation for durable, long-term growth.”
Steve Vondran, American Tower’s Chief Executive Officer
The Simply Good Foods Company reported fiscal fourth quarter 2026 net sales of $333.3 million, a 9.7% decrease year-over-year, and net income of $30.5 million. The company provided a fiscal year 2027 outlook expecting net sales to decline between 13% and 17% as it continues a business turnaround and marketing overhaul for its Quest, Atkins, and OWYN brands.
Term
FY2026
“Fiscal 2026 was a year of decisive action. We recognized that our performance was not where it needed to be and moved quickly to reset the business. We aligned the organization around a focused set of priorities, accelerated work to improve our cost structure, strengthened our financial flexibility, and overhauled our marketing approach across Quest, Atkins, and OWYN.”
Joe Scalzo, President and Chief Executive Officer
“Fiscal 2027 will be a challenging but important year in our turnaround. While we expect significant declines in net sales and Adjusted EBITDA, we are taking the actions necessary to restore the economic foundation of the business and rebuild brand momentum.”
SoFi Technologies reported record Q3 2026 financial results with adjusted net revenue increasing 44% year-over-year to $1.4 billion and net income rising 73% to $241 million. Based on strong business momentum, the company raised its full-year 2026 guidance and introduced a 2027 outlook projecting $6.4 billion in adjusted net revenue.
Term
Q3 2026
“We had exceptional Q3 results against the backdrop of any environment, but they are even more remarkable given how 2026 has unfolded. Our focus is simple. We are adding more members, who are using more products, and generating more revenue per product to create the most value for our shareholders over the long run.”
Asbury Automotive Group reported Q3 2026 revenue of $4.4 billion and net income of $105 million ($5.84 per diluted share). The company completed its company-wide Tekion technology platform conversion and reported a 4.5% sequential increase in used retail unit volume.
Term
Q3 2026
“We have completed one of the most ambitious technology initiatives in Asbury’s history, every active store is now operating on Tekion. Our teams converted 47 stores in the third quarter alone, the most in any single quarter, and finished the remaining active stores in October to bring the rollout across the finish line.”
Dan Clara, Asbury’s President and Chief Executive Officer
“With one modern platform now powering the entire company, we have built a strong foundation to serve our guests, make faster decisions, and operate more efficiently.”
Dan Clara, Asbury’s President and Chief Executive Officer
PayPal reported third-quarter 2026 financial results with net revenues increasing 2% to $8.6 billion and non-GAAP EPS rising 8% to $1.45. The company also declared a cash dividend of $0.14 per share and repurchased $1.5 billion of its common stock during the quarter.
Term
Q3 2026
“I’m pleased with our third-quarter performance and the momentum we are seeing across the business, and we are raising our full-year non-GAAP guidance for transaction margin dollars and EPS. We are beginning to see our strategy translate into our financial results, with strong contributions from our key growth areas and increasing diversification. We are making good progress in our multi-year transformation, and while there is more work to do, we are increasingly confident in our path to durable, profitable growth and remain focused on execution.”
Corning reported third-quarter 2026 core sales of $5.08 billion, up 19% year-over-year, driven by 44% growth in Optical Communications and strong Gen AI product demand. The company also secured four long-term, multibillion-dollar customer agreements, including deals with Verizon and AT&T, as part of its 'Springboard' growth plan.
Term
Q3 2026
“We delivered an outstanding third quarter. Year over year, core sales grew 19% to $5.08 billion, and core EPS grew 36% to $0.91. We expanded core gross margin 150 basis points to 40.5%, core operating margin 310 basis points to 22.7%, and core ROIC 330 basis points to 16.7% – with strong adjusted free cash flow of $661 million, while investing more than half a billion in capital expenditures to address demand for our innovations. Our strong results provide excellent proof points of the acceleration of growth outlined in our ‘20-30-40’ Springboard Plan.”
Wendell P. Weeks, chairman, chief executive officer, and president
“When we upgraded Springboard in May, we laid out a path to double our annualized sales run rate from $20 billion to $40 billion by the end of 2030. We also expect to grow earnings faster than sales, with significantly higher ROIC and substantially more free cash flow. To support that growth, we have steadily added capacity, backed by long-term customer agreements that share the cost and risk of expansions. As a result, we have been able to grow adjusted free cash flow to $2.27 billion through the first nine months of 2026 while investing to meet demand.”
Ed Schlesinger, executive vice president and chief financial officer
Xylem reported Q3 2026 revenue of $2.2 billion and adjusted EPS of $1.44, while announcing a strategic reorganization into three segments and the intent to divest its Applied Water International and Specialty Flow Control businesses. The company lowered its full-year 2026 revenue guidance to $8.95 billion and adjusted EPS to a range of $5.40 to $5.45 due to project timing and cautious customer spending.
Invesco Ltd. reported Q3 2026 financial results featuring $35.1 billion in net long-term inflows and ending AUM of $2.5 trillion. The company expanded its adjusted operating margin to 40.7% and repurchased $1.5 billion of Series A Preferred Stock from MassMutual, funded by a new bank term loan.
Term
Q3 2026
“We continue to execute against our strategic priorities and leverage our advantageous global market position to deliver for clients and shareholders. We generated 6% annualized organic growth, driven by $35 billion of net long-term inflows, alongside $47 billion of global liquidity net inflows.”
Andrew Schlossberg, President and CEO
“Strong operating performance is enhancing our financial flexibility and supporting continued progress in strengthening the balance sheet. We have repurchased an additional $1.5 billion of the preferred stock held by MassMutual, bringing total repurchases to $3 billion over the past 18 months and leaving $1 billion outstanding.”
JAKKS Pacific reported net sales of $254.2 million for the third quarter of 2026, a significant increase from $211.2 million in the prior year. Net income for the quarter rose to $29.9 million, or $2.48 per diluted share, driven by strong gross profit margins of 32.1%.
Armstrong World Industries reported net sales of $475.8 million for the third quarter of 2026, an 11.9% increase over the prior year, driven by growth in both operating income and net earnings. The company maintained strong liquidity despite significant cash outflows for treasury stock repurchases totaling $213.1 million during the first nine months of the year.